TORONTO, April 23, 2018 -- Axiom Real-Time Metrics, premier provider of unified eClinical solutions and services, is exhibiting at Clinical Operations in Oncology Trials West on April 24th and 25th in Burlingame, California.
The 2018 event is the 5th annual edition of the conference and brings together leading pharma and biotech professionals working in the oncology space from across the West Coast region.
“Fusion eClinical Suite provides uniquely tailored reports to support clinical oncology studies, including tumour response assessment and tracking, patient profiles, and biomarker reports. Axiom’s client roster includes many sponsors working on global oncology and plasma cell disorders including studies for the treatment of Multiple Myeloma, AML, CML, Hodgkin Lymphoma and Leukemia, among others. The easy-to-use, modular suite of tools is extremely flexible, enabling sponsors to manage all study data from Phase I to complex Phase III trials without having to change platforms or source additional vendors. It works exceptionally well for all studies, supporting US to global studies and enabling them to operate with far greater efficiency - speeding time to market,” shared Dr. Robert Arbeit, Chief Clinical Scientist.
Andrew Schachter, Founder and CEO concluded, “Our established ROI and delivery positions us as both cost efficient and best-in-class. We invite attendees to come and visit us at Booth 4 for a conversation and tailored demo over coffee.”
About Axiom Real-Time Metrics
Headquartered in Toronto, Canada, Axiom delivers intuitive, powerful and cost-effective eClinical solutions and services focused around your entire study. Services include: DM, Biostatistics and Pharmacovigilance. Axiom's eClinical suite, Fusion, delivers a powerful range of innovative end-user focused, unified functionality and 15 modules. Axiom serves as the Connected Hub for your entire clinical study data and operational needs. Fusion Delivers: EDC, DM, IWRS, CTMS, Inventory Management, IVR, Patient Portal, AE/SAE Tracking, Safety Database, Central Lab, Imaging, eTMF, and 24/7 Project and Clinical Data Reporting. For more information, please visit http://www.axiommetrics.com/.
Contact
[email protected]
+1.877.321.9191
PR Contact
Sarah Glofcheskie
[email protected]
+1.647.588.9073


SEC Probes Banks Over Situational Awareness Hedge Fund Collapse
Trump Buys SpaceX Shares After Record IPO
Trian Drops Wendy’s Take-Private Bid Plans, Shares Plunge 14%
Luxshare Shares Rise as First-Half Profit Jumps 18%
Woodside Drops $5 Billion Clean Energy Plan as Profit Rises 7%
Bathla Group Hires Administrators as Australia Housing Slump Deepens
BofA Names ASML Top Semiconductor Equipment Pick on Growth, Valuation
SoftBank Eyes $20 Billion Bond Sale to Refinance OpenAI Loan
SK Hynix Shares Fall as Workers Reject Wage Deal
Australia’s Big Four Banks Face Mortgage Slowdown as Valuations Draw Scrutiny
BNP Paribas, KB Kookmin Eye $2 Billion Techcombank Stake
Meta, U.S. States Discuss Settlement in Teen Addiction Trial
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
Adidas, Puma Shares Fall as Dick’s Sporting Goods Cuts Outlook
Nvidia Revenue Soars 106% as AI Demand Hits ‘Inflection Point’
U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China 



